Bank of America
CLLS

Bank of America’s Cellectis CLLS Stock Holding History

Bank of America’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,514
Closed -$17K – 5938
2025
Q4 		$17K Buy
3,514
+3,437
+4,464% +$14.4K ﹤0.01% 6079
2025
Q3 		$220 Hold
77
– – ﹤0.01% 7713
2025
Q2 		$117 Hold
77
– – ﹤0.01% 7943
2025
Q1 		$95 Hold
77
– – ﹤0.01% 7840
2024
Q4 		$139 Hold
77
– – ﹤0.01% 7667
2024
Q3 		$163 Buy
77
+75
+3,750% +$163 ﹤0.01% 7612
2024
Q2 		$4 Sell
2
-34
-94% -$89 ﹤0.01% 8133
2024
Q1 		$95 Buy
36
+34
+1,700% +$94 ﹤0.01% 7402
2023
Q4 		$6 Hold
2
– – ﹤0.01% 7836
2023
Q3 		$3 Hold
2
– – ﹤0.01% 7692
2023
Q2 		$4 Sell
2
-9,153
-100% -$17.5K ﹤0.01% 7612
2023
Q1 		$17.7K Buy
9,155
+2,036
+29% +$5.1K ﹤0.01% 6786
2022
Q4 		$14.9K Sell
7,119
-11,944
-63% -$27.1K ﹤0.01% 6830
2022
Q3 		$44K Sell
19,063
-2,753
-13% -$8.34K ﹤0.01% 6729
2022
Q2 		$61K Sell
21,816
-21,799
-50% -$76.8K ﹤0.01% 6731
2022
Q1 		$198K Sell
43,615
-21,054
-33% -$116K ﹤0.01% 6468
2021
Q4 		$525K Buy
64,669
+52,400
+427% +$515K ﹤0.01% 5814
2021
Q3 		$155K Buy
12,269
+2,643
+27% +$36.6K ﹤0.01% 6465
2021
Q2 		$148K Sell
9,626
-8,127
-46% -$137K ﹤0.01% 6284
2021
Q1 		$358K Sell
17,753
-26,709
-60% -$660K ﹤0.01% 5634
2020
Q4 		$1.2M Buy
44,462
+24,053
+118% +$540K ﹤0.01% 4351
2020
Q3 		$377K Buy
20,409
+15,728
+336% +$279K ﹤0.01% 4925
2020
Q2 		$83K Sell
4,681
-147,874
-97% -$2.25M ﹤0.01% 5764
2020
Q1 		$1.4M Buy
152,555
+147,550
+2,948% +$2.2M ﹤0.01% 3774
2019
Q4 		$86K Buy
5,005
+2,133
+74% +$28.5K ﹤0.01% 6051
2019
Q3 		$30K Sell
2,872
-434
-13% -$5.83K ﹤0.01% 6489
2019
Q2 		$51K Sell
3,306
-320
-9% -$5.71K ﹤0.01% 6289
2019
Q1 		$66K Sell
3,626
-74
-2% -$1.31K ﹤0.01% 6081
2018
Q4 		$61K Sell
3,700
-15,053
-80% -$349K ﹤0.01% 6136
2018
Q3 		$529K Buy
18,753
+13,179
+236% +$379K ﹤0.01% 4913
2018
Q2 		$158K Buy
5,574
+121
+2% +$3.6K ﹤0.01% 5545
2018
Q1 		$172K Sell
5,453
-1,106
-17% -$34.9K ﹤0.01% 5454
2017
Q4 		$191K Buy
6,559
+1,174
+22% +$32K ﹤0.01% 5433
2017
Q3 		$153K Sell
5,385
-5,079
-49% -$131K ﹤0.01% 5499
2017
Q2 		$270K Buy
10,464
+254
+2% +$6.06K ﹤0.01% 5183
2017
Q1 		$245K Sell
10,210
-343
-3% -$7.21K ﹤0.01% 5231
2016
Q4 		$179K Sell
10,553
-5,758
-35% -$106K ﹤0.01% 5369
2016
Q3 		$393K Buy
16,311
+258
+2% +$6.75K ﹤0.01% 4778
2016
Q2 		$427K Buy
16,053
+1,366
+9% +$40K ﹤0.01% 4754
2016
Q1 		$404K Buy
14,687
+3,613
+33% +$87K ﹤0.01% 4724
2015
Q4 		$343K Buy
11,074
+10,074
+1,007% +$306K ﹤0.01% 5049
2015
Q3 		$26K Buy
1,000
+750
+300% +$25.1K ﹤0.01% 6222
2015
Q2 		$9K Sell
250
-4,750
-95% -$167K ﹤0.01% 6618
2015
Q1 		$173K Buy
+5,000
New +$181K ﹤0.01% 5018

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bank of America's CLLS Position: Q1 2026 in Review

Bank of America sold out of Cellectis (CLLS) in Q1 2026, closing a stake of 3,514 shares — an estimated $17K sold.

Bank of America first reported a position in CLLS in Q1 2015 and held it in 44 quarters. The position peaked at $1.4M in Q1 2020. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Bank of America reported no remaining Cellectis position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 3,514 Cellectis shares in Q1 2026, an estimated $17K.
  • Bank of America first reported a position in Cellectis in Q1 2015 and held it in 44 quarters.
  • Bank of America's Cellectis position peaked at $1.4M in Q1 2020.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.